Who can benefit more from its twelve-week treatment: A prospective cohort study of blonanserin for patients with schizophrenia

doi:10.5498/wjp.v14.i11.1735

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 11

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (1010)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series, Tables (1-5) series.

Item

Count

PDF

HTML

505

Figures (1-2)

Tables (1-5)

Sum=628

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

120

Sum=199

Publishing Process of This Article

Item

Count

Browse

Download

128

Sum=151

Nov 19, 2024 (publication date) through Dec 23, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Psychiatry

ISSN

2220-3206

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Prospective Study

World J Psychiatry. Nov 19, 2024; 14(11): 1735-1745
Published online Nov 19, 2024. doi: 10.5498/wjp.v14.i11.1735

Full Size Figure Download Figure

Figure 1 Trend of changes in brief psychiatric rating scale total score of patients with schizophrenia. BPRS: Brief psychiatric rating scale.

Citation: Xu BY, Jin K, Wu HS, Liu XJ, Wang XJ, Sang H, Li KQ, Sun MJ, Meng HQ, Deng HL, Xun ZY, Yang XD, Zhang L, Li GJ, Zhang RL, Cai DF, Liu JH, Zhao GJ, Liu LF, Wang G, Zhao CL, Guo B, Jin SC, Huang LY, Yang FD, Zheng JM, Zhan GL, Fang MS, Meng XJ, Zhang GY, Li HM, Liu XL, Li JH, Wu B, Li HY, Chen JD. Who can benefit more from its twelve-week treatment: A prospective cohort study of blonanserin for patients with schizophrenia. World J Psychiatry 2024; 14(11): 1735-1745
URL: https://www.wjgnet.com/2220-3206/full/v14/i11/1735.htm
DOI: https://dx.doi.org/10.5498/wjp.v14.i11.1735